Dalmia Bharat Sugar Posts Q3 Profit Jump, Declares ₹4.50 Dividend Amid Revenue Drop

CHEMICALS
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Dalmia Bharat Sugar Posts Q3 Profit Jump, Declares ₹4.50 Dividend Amid Revenue Drop
Overview

Dalmia Bharat Sugar reported a 17.3% year-on-year rise in Profit After Tax (PAT) to ₹69.56 Cr for Q3 FY26, even as revenues declined 28.6% to ₹697.75 Cr. EBITDA grew 13.6% with margins improving to 21.1%. However, for the nine months ended December 31, 2025, PAT fell 20.8% to ₹132.14 Cr on a 24.6% revenue increase. The company declared an interim dividend of ₹4.50 per share and approved ₹107 Cr in capital expenditure for biogas and efficiency projects.

📉 The Financial Deep Dive

Dalmia Bharat Sugar and Industries Limited has reported a mixed financial performance for the third quarter and nine months ended December 31, 2025 (Q3 FY26 and 9M FY26).

The Numbers:
For Q3 FY26, the company posted a revenue of ₹697.75 Cr, a significant 28.6% decrease year-on-year (YoY) from ₹837.67 Cr in Q3 FY25. Despite the top-line contraction, profitability saw a marked improvement. Profit Before Tax (PBT) increased by 22.9% YoY to ₹92.95 Cr. Estimated EBITDA rose 13.6% YoY to ₹125.90 Cr, with the EBITDA margin expanding from 13.2% to a strong 21.1%. Profit After Tax (PAT) grew 17.3% YoY to ₹69.56 Cr, and Basic and Diluted Earnings Per Share (EPS) improved to ₹8.59 from ₹7.33. The PAT margin consequently improved to 9.6% from 6.9% YoY.

However, the performance for the nine months ended December 31, 2025 (9M FY26) presented a different picture. Revenue from operations showed robust growth, climbing 24.6% YoY to ₹2,627.35 Cr. Yet, profitability metrics declined. PBT fell 4.8% YoY to ₹176.87 Cr. EBITDA saw a marginal decrease of 0.8% YoY to ₹276.30 Cr, with the EBITDA margin contracting significantly to 10.5% from 13.2% in the prior year period. PAT dropped 20.8% YoY to ₹132.14 Cr, and EPS decreased to ₹16.35 from ₹20.60 YoY. The PAT margin for 9M FY26 stood at 4.9%, down from 7.7% in 9M FY25.

The Quality & Strategic Moves:
The quarter-on-quarter (QoQ) performance is not detailed in the provided text. The improvement in Q3 margins, despite lower revenues, suggests better operational efficiencies and potentially a favourable product mix or cost management. The commencement of commercial operations of its converted grain-based distillery facility likely contributed positively to the quarterly results. The company also noted incremental impacts from new Labour Codes and increased sugarcane prices.

Dalmia Bharat Sugar's board has approved significant capital expenditure projects totaling ₹107 Crore. A Compressed Bio-Gas (CBG) project with a 13 TPD capacity at its Kolhapur Distillery was sanctioned for ₹58 Crore, aiming to utilize spent wash, with a projected completion within 9 months. Additionally, a Steam Saving Project at the Jawaharpur Unit was approved for ₹49 Crore, designed to reduce steam and bagasse consumption, expected to be completed in 7 months. These investments signal a strategic push towards sustainability, energy efficiency, and potentially diversifying revenue streams.

Interim Dividend Declared:
In a shareholder-friendly move, the company declared an interim dividend of ₹4.50 per equity share for FY 2025-26. The record date for this dividend is February 11, 2026.

Subsidiary Acquisition:
Eagle Agrotech Holdings Limited became a subsidiary of the company on December 18, 2025, indicating potential strategic expansion or consolidation.

🚩 Risks & Outlook

The primary concern arising from the results is the significant margin contraction observed in the nine-month period, particularly the EBITDA margin falling from 13.2% to 10.5%. While the Q3 showed margin recovery, sustained profitability for the full year will depend on managing costs and input prices effectively. The revenue decline in Q3 also warrants monitoring, though it could be seasonal or linked to specific market conditions. The approved capital expenditure projects are crucial for future growth and operational efficiency, especially the CBG project which taps into the growing bio-energy market. Investors will watch the execution and impact of these capex initiatives, along with the company's ability to maintain improved margins going forward.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.